Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Myeloma Kidney Therapies
Myeloma Kidney Therapies
Consider myeloma kidney therapies to improve kidney function that may be impaired by myeloma. Remember that kidney health can be negatively affected by both the myeloma itself as well as conventional therapies prescribed by oncology.
While the research below talks about nutritional supplements to enhance kidney health, remember that there are a number of foods that also enhance kidney function.
To learn the basic concepts surrounding myeloma kidney, watch the short video below.
Kidney Problems Associated with Myeloma
I am a long-term MM survivor and MM cancer coach. Living with MM since my diagnosis in early 1994 has taught me that conventional oncology adheres strictly to all things Food and Drug Administration. This is how oncology works in the U.S. No problem.
But please don’t be disappointed when you learn that your oncologist doesn’t know much about evidence-based but non-conventional kidney health therapies.
Scroll down the page, post a question or a comment about myeloma kidney therapies. I will reply to you ASAP.
Thank you,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
How Does Multiple Myeloma Affect the Kidneys?
Kidney failure is common in people with multiple myeloma (MM) and is usually caused by the toxic effects of monoclonal light chains.
“Excess antibodies can damage the filtration apparatus of the kidney or the kidney tubule itself, resulting in kidney dysfunction or frank kidney failure,” said Michael Scola, MD, an oncologist and the director of Benign Hematology at Atlantic Hematology/Oncology in Morristown, New Jersey.
About 20% to 40% of people with MM have some degree of kidney impairment at the time of diagnosis. When people with MM develop kidney diseases, it is sometimes called myeloma kidney. This is associated with a higher risk of death…
The aggregation of the two proteins can form an undegradable cast that cannot be excreted through urine. This can block kidney tubules and glomeruli, leading to inflammation, atrophy, and scarring of kidney tissues.
MM can also affect the kidneys when it causes excess calcium in the blood – a condition called hypercalcemia. “Hypercalcemia causes the kidney to excrete excess fluid, directly damages the kidney, and can precipitate within the kidney as renal stones,” said Dr. Scola…”
Supplements Show Potential for Kidney Stone Prevention
Certain dietary supplements inhibit the formation, growth, and aggregation of calcium oxalate kidney stones and may ultimately aid in prevention, according to new research presented this week at NUTRITION 2025, the annual meeting of the American Society for Nutrition…
The new findings, presented at NUTRITION 2025, represent the team’s efforts to investigate whether dietary supplements could modulate these oxidative modifications, potentially preventing stones from forming…
Inhibitory Effects Revealed
Using crystallization, growth, and aggregation assays, the team compared the modulatory effects of caffeine, epigallocatechin-3-gallate (EGCG), N-acetylcysteine (NAC), resveratrol, and trigonelline (at 1, 10, and 100 μM — ie, within their physiologic range in urine) on calcium oxalate crystals.
They found that the supplements had diverse effects:
- Caffeine inhibited crystal formation,
- EGCG inhibited crystal formation and growth,
- NAC inhibited crystal aggregation,
- Resveratrol inhibited crystal growth, a
- nd trigonelline inhibited crystal growth and aggregation.
myeloma kidney therapies myeloma kidney therapies